Marram Ventures

Profile

Marram Ventures is a healthcare-focused venture capital firm based in Sheridan, Wyoming. It was founded as an independent entity following the transition of Arcis Fund I and related investment management activities from The 4100 Group. The firm is led by Scott Lancaster, MD, MBA, a former radiologist turned venture investor, and Mariya Filipova, MBA, a healthcare executive with a background in Care Convergence. Marram Ventures aims to foster whole-person healthcare by integrating physical, mental, and oral health under a unified care system.

Marram Ventures invests in patient-focused, technology-enabled companies, focusing on convergent care delivery, diagnostics & devices, and connective infrastructure. The firm typically writes checks ranging from $1 to $3 million in Seed through Series B stages. Managing a total of $80 million in assets under management and advisement, Marram Ventures operates out of Sheridan, Wyoming, with additional presences in Saugatuck, Michigan, and Cambridge, Massachusetts.

Notable investments include Clarapath - a company specializing in pathology-automation robotics, Proclaim (Fresh Health) - an oral systemic health innovator, and Root Functional Medicine - which focuses on integrative healthcare solutions. The firm continues to support its existing portfolio while seeking to align new investments with its healthcare convergence thesis.